Alessandra Gennari
0000-0002-0928-2281
Publication & Citation Trends
Publications
0 total
Abstract PS4-06-15: Safety Run-In Phase of the ATRiBRAVE trial: a Phase II Study Evaluating Ceralasertib Priming Followed by Durvalumab/Nab-Paclitaxel to Restore Immunotherapy Sensitivity in Advanced Triple Negative Breast Cancer (TNBC)
Cited by 0
Semantic Scholar
Abstract PS1-10-29: Complete tumor response during first-line endocrine therapy (ET) plus Cyclin Dependent Kinase 4/6 inhibitors (CDK4/6i) predicts excellent clinical outcomes in patients with Hormone Receptor-positive, Human Epidermal growth factor Receptor 2-negative advanced Breast Cancer (HR+/HE
Cited by 0
Semantic Scholar
Abstract PD4-10: The prognosis of invasive early hormone receptor positive HER2 negative breast cancer in women harboring a pathogenic or likely pathogenic TP53 germline variant
Cited by 0
Semantic Scholar
Abstract PS3-04-29: Machine Learning predicts early tumor progression in Hormone Receptor-positive, Human Epidermal growth factor Receptor 2-negative (HR+/HER2-) advanced breast cancer (aBC) patients treated with first-line endocrine therapy (ET) plus Cyclin Dependent Kinase 4/6 inhibitors (CDK4/6i)
Cited by 0
Semantic Scholar
Abstract PS4-01-16: The transcriptomic profile of circulating T lymphocytes is associated with response to neoadjuvant therapy in patients with early breast cancer
Cited by 0
Semantic Scholar
Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period OA
Cited by 0
Semantic Scholar
Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica
Cited by 0
Semantic Scholar
504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer OA
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(135)
Cancer Treatment and Pharmacology
(99)
Diabetes Treatment and Management
(85)
Advanced Breast Cancer Therapies
(71)
Breast Cancer Treatment Studies
(68)
Affiliations
University of Pisa
Twitter (United States)
Goethe University Frankfurt
University of Insubria
University of Modena and Reggio Emilia